Join the club for FREE to access the whole archive and other member benefits.

Young blood antiaging trial raises questions


Key points from article :

Ambrosia ( young plasma trial is open to anyone 35 and older.

Participants charged $8000 for lab tests and a one-time treatment.

Each person will receive roughly 1.5 liters of plasma from a donor under age 25.

Their blood will be tested for more than 100 biomarkers that may vary with age, from hemoglobin level to inflammation markers.

Mentioned in this article:

Click on resource name for more details.


Biotechnology company focused on treating neurodegenerative and other age-related diseases


Offers young blood plasma transfers after running a trial in 2016-18

Jesse Karmazin

CEO of the blood transfusion company Ambrosia.

Tony Wyss-Coray

Professor at Stanford University School of Medicine